Tuhura Biosciences Stock Today
| HURA Stock | 3.85 1.05 37.50% |
PerformanceWeak
| Odds Of DistressVery High
|
TuHURA Biosciences is trading at 3.85 as of the 20th of March 2025, a 37.50 percent increase since the beginning of the trading day. The stock's open price was 2.8. TuHURA Biosciences has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. TuHURA Biosciences symbol was changed from KTRA on 18th of October 2024. Note, on January 8, 2025, Representative Laurel Lee of US Congress acquired under $15k worth of TuHURA Biosciences's common stock.
Moving together with TuHURA Stock
Moving against TuHURA Stock
TuHURA Stock Highlights
| Older Symbol | KTRA |
| CEO President | James MD |
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Biotechnology, Healthcare (View all Sectors) |
TuHURA Biosciences (HURA) is traded on NASDAQ Exchange in USA. It is located in 10500 University Center Drive, Tampa, FL, United States, 33612 and employs 1 people. TuHURA Biosciences was previously known as KTRA Old and was traded on NASDAQ Exchange under the symbol KTRA. TuHURA Biosciences is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 141.65 M. TuHURA Biosciences conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 26 M outstanding shares of which 1.03 M shares are currently shorted by private and institutional investors with about 0.0 trading days to cover.
TuHURA Biosciences generates negative cash flow from operations
Check TuHURA Biosciences Probability Of Bankruptcy
TuHURA Biosciences Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. TuHURA Biosciences market risk premium is the additional return an investor will receive from holding TuHURA Biosciences long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.0204 | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | 0.8572 | |||
| Sortino Ratio | 0.024 |
TuHURA Stock Against Markets
TuHURA Biosciences Corporate Executives
Elected by the shareholders, the TuHURA Biosciences' board of directors comprises two types of representatives: TuHURA Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of TuHURA. The board's role is to monitor TuHURA Biosciences' management team and ensure that shareholders' interests are well served. TuHURA Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, TuHURA Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Patricia Lawman | CoFounder | Profile | |
| Michael Lawman | CoFounder | Profile | |
| Dan CPA | Executive CFO | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in TuHURA Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TuHURA Biosciences. If investors know TuHURA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TuHURA Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of TuHURA Biosciences is measured differently than its book value, which is the value of TuHURA that is recorded on the company's balance sheet. Investors also form their own opinion of TuHURA Biosciences' value that differs from its market value or its book value, called intrinsic value, which is TuHURA Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TuHURA Biosciences' market value can be influenced by many factors that don't directly affect TuHURA Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TuHURA Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if TuHURA Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TuHURA Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.